In 2023 the United States Court of Appeals for the Federal Circuit issued a precedential ruling in favor of SNIPR in a CRISPR patent interference case with Rockefeller University, thereby upholding ...
Last year, the Vanguard S&P 500 Growth ETF ranked as the biggest winner among Vanguard's exchange-traded funds (ETFs). That's not surprising. The ETF owns big stakes in stocks like Nvidia, Meta ...
The shortage of Novo Nordisk’s (NVO) blockbuster weight loss drugs has been resolved, according to the U.S. Food and Drug Administration ...
Novo Nordisk A/S was the biggest leader among large stocks during the session, gaining 5.8%, and DNO ASA gained 5.4%. Carlsberg A/S Series A rounded out the top three leaders on Friday, with shares ...
We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Approval Drop. In this article, we ...
The resolution could potentially restrict how telehealth programs offer cheaper versions known as compounded drugs ...
Mexico, China and Canada were the largest importers for the US in 2023, and the first targets of US President Donald Trump’s ...
The FDA announcement confirms that the U.S. supply of both prescription-only drugs now meets or exceeds the current and ...
Blood proteins serve as crucial indicators of health and disease risk throughout development. Now, researchers at the ...
A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.
European stocks rose for a ninth straight week, boosted by shares of chemicals companies and Novo Nordisk A/S gains. Traders are also looking ahead to German elections on Sunday.
Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...